Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» NASDAQ
NASDAQ
Three more biotechs hit Nasdaq as the sector, now with more than $13B raised, continues barreling toward record
Endpoints
Wed, 09/15/21 - 10:56 am
IPOs
SPACs
NASDAQ
Pasithea Therapeutics
Tyra Biosciences
DiCE Therapeutics
Antiviral nasal drop maker does the Nasdaq shuffle as part of minor SPAC reverse merger
Endpoints
Tue, 08/31/21 - 11:02 am
Revelation Biosciences
antivirals
SPACs
NASDAQ
BioCryst scraps $200M offering after seeing share price slide
Fierce Biotech
Wed, 08/11/21 - 12:08 pm
Biocryst
NASDAQ
funding
Three Biopharma Companies Made Public Debut on Nasdaq Exchange
BioSpace
Thu, 07/29/21 - 10:59 pm
IPOs
Nuvalent
Rallybio
Icosavax
NASDAQ
Amid virtual trial craze, Science 37 earns unicorn status and a trip to Nasdaq on the back of SPAC deal
Endpoints
Fri, 05/7/21 - 10:47 am
Science 37
SPAC
NASDAQ
virtual clinical trials
Two Biotechs Gear Up for Nasdaq Debut
BioSpace
Tue, 05/4/21 - 10:47 pm
Gyroscope Therapeutics
Talaris Therapeutics
IPOs
NASDAQ
3 very different biotechs all file for the same IPO goal: A big raise on Nasdaq
Fierce Biotech
Mon, 04/19/21 - 11:08 am
IPOs
NASDAQ
Talaris Therapeutics
Gyroscope Therapeutics
Sagimet Biosciences
It takes two to Tango: The biotech using CRISPR to discover new cancer gene targets rides a $353M SPAC deal to Nasdaq
Endpoints
Wed, 04/14/21 - 10:02 am
Tango Therapeutics
SPAC
NASDAQ
Reneo Pharmaceuticals and VectivBio Prepare to Begin Trading on the Nasdaq
BioSpace
Thu, 04/8/21 - 07:51 pm
Reneo Pharmaceuticals
VectivBio
IPOs
NASDAQ
Vaccitech confidentially files for Nasdaq IPO
Endpoints
Wed, 04/7/21 - 07:20 pm
Vaccitech
IPOs
NASDAQ
COVID-19
vaccines
Three Biopharma Companies Making Their Nasdaq Debut
BioSpace
Mon, 03/29/21 - 10:49 am
IPOs
NASDAQ
Design Therapeutics
Edgewise Therapeutics
Ikena Oncology
British T-cell cancer biotech Achilles Therapeutics guns for $176M IPO
Fierce Biotech
Fri, 03/26/21 - 10:44 am
IPOs
Achilles Therapeutics
immuno-oncology
NASDAQ
The Ides of March bring no misfortune to biotech, as industry logs second-busiest IPO week of 2021
Endpoints
Fri, 03/19/21 - 11:22 am
IPOs
NASDAQ
Instil Bio
Connect Biopharma
Finch Therapeutics
Gain Therapeutics
Biotech IPO market looks to ramp back up as BMS partner Ikena and its immunometabolism therapies eye public offering
Endpoints
Mon, 03/8/21 - 09:15 pm
IPOs
Ikena Oncology
Kyn Therapeutics
NASDAQ
Nautilus set to go public in reverse merger with Perceptive SPAC, aims to test proteomics platform with big-name backers
Endpoints
Tue, 02/9/21 - 11:21 am
Nautilus Biotechnology
NASDAQ
SPAC
IPOs
reverse merger
M&A
Arya Sciences
Life Sciences Companies Ringing the Nasdaq Bell this Week
BioSpace
Thu, 02/4/21 - 08:10 pm
IPOs
NASDAQ
Sana Biotechnology
Sensei Biotherapeutics
Landos Biopharma
Aspira Women's Health
Equillium
Seneca Biopharma merges with Leading BioSciences, becoming Palisade Bio
Fierce Biotech
Thu, 12/17/20 - 11:09 am
Seneca Biopharma
Leading BioSciences
Palisade Bio
NASDAQ
M&A
BioAtla heads for Nasdaq on Wednesday following $189M IPO, going public with its pH-detecting cancer treatments
Endpoints
Wed, 12/16/20 - 11:32 am
BioAtla
IPOs
NASDAQ
Kinnate Biopharma upsizes IPO and prices above range at $20 a share
Marketwatch
Fri, 12/4/20 - 10:53 am
Kinnate Biopharma
IPOs
NASDAQ
small molecule kinase inhibitors
Pfizer Spinoff Cerevel Therapeutics Begins Trading on the Nasdaq
BioSpace
Wed, 10/28/20 - 11:09 pm
Pfizer
Cerevel Therapeutics
SPAC
Arya Sciences
NASDAQ
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »